Skip to main content

Closed

COGT: Cogent Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-42.8%

Financially safe

Stretched

Debt / equity0.39×

Interest coverage-84.7×

Current ratio15.14×

Cogent Biosciences, Inc.

COGTNASDAQ Global Select·USD·Closed

Cogent Biosciences, Inc.

COGTNASDAQ·USD·Closed

$38.93

−5.88%

$38.93

−$2.43 (5.88%)

52W Range

86thpctl

Volume

0.62×avg

Mkt Cap

6.65BUSD

P/E

-12.6TTM

Div Yield

–ann

52W Range

86thpctl

Volume

0.62×avg

Market Cap

6.65BUSD

P/E Ratio

-12.6TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings